STAAR Surgical Company (STAA) Revenue & Revenue Breakdown
STAAR Surgical Company Revenue Highlights
Latest Revenue (Y)
$322.42K
Latest Revenue (Q)
$88.59M
Main Segment (Y)
Implantable Collamer Lenses
Main Geography (Y)
Other Countries
STAAR Surgical Company Revenue by Period
STAAR Surgical Company Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-29 | $322.42K | -99.89% |
| 2022-12-30 | $284.39M | 23.40% |
| 2021-12-31 | $230.47M | 41.00% |
| 2021-01-01 | $163.46M | 8.84% |
| 2020-01-03 | $150.19M | 21.16% |
| 2018-12-28 | $123.95M | 36.80% |
| 2017-12-29 | $90.61M | 9.92% |
| 2016-12-30 | $82.43M | 6.88% |
| 2016-01-01 | $77.12M | 2.85% |
| 2015-01-02 | $74.99M | 3.84% |
| 2014-01-03 | $72.22M | 13.22% |
| 2012-12-28 | $63.78M | 1.62% |
| 2011-12-30 | $62.77M | 14.21% |
| 2010-12-31 | $54.96M | -27.06% |
| 2010-01-01 | $75.34M | 0.60% |
| 2009-01-02 | $74.89M | 26.16% |
| 2007-12-28 | $59.36M | 5.47% |
| 2006-12-29 | $56.28M | 9.71% |
| 2005-12-30 | $51.30M | -0.74% |
| 2004-12-31 | $51.69M | 2.43% |
| 2004-01-02 | $50.46M | 4.58% |
| 2003-01-03 | $48.25M | -3.96% |
| 2001-12-28 | $50.24M | -6.94% |
| 2000-12-29 | $53.99M | -8.50% |
| 1999-12-31 | $59.00M | 8.86% |
| 1999-01-01 | $54.20M | 27.53% |
| 1998-01-02 | $42.50M | 0.71% |
| 1997-01-03 | $42.20M | 21.61% |
| 1995-12-29 | $34.70M | 26.64% |
| 1994-12-31 | $27.40M | 36.32% |
| 1993-12-31 | $20.10M | - |
STAAR Surgical Company generated $322.42K in revenue during NA 2023, up -99.89% compared to the previous quarter, and up 0.26% compared to the same period a year ago.
STAAR Surgical Company Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-27 | $88.59M | -10.52% |
| 2024-06-28 | $99.00M | 27.99% |
| 2024-03-29 | $77.36M | 1.42% |
| 2023-12-29 | $76.27M | -5.02% |
| 2023-09-29 | $80.31M | -13.00% |
| 2023-06-30 | $92.31M | 25.54% |
| 2023-03-31 | $73.53M | 14.81% |
| 2022-12-30 | $64.04M | -15.78% |
| 2022-09-30 | $76.05M | -6.23% |
| 2022-07-01 | $81.10M | 28.32% |
| 2022-04-01 | $63.20M | 7.12% |
| 2021-12-31 | $59.00M | 1.11% |
| 2021-10-01 | $58.35M | -6.44% |
| 2021-07-02 | $62.37M | 22.89% |
| 2021-04-02 | $50.75M | 10.34% |
| 2021-01-01 | $46.00M | -2.30% |
| 2020-10-02 | $47.08M | 33.78% |
| 2020-07-03 | $35.19M | 0.02% |
| 2020-04-03 | $35.19M | -9.51% |
| 2020-01-03 | $38.88M | -0.44% |
| 2019-09-27 | $39.05M | -1.54% |
| 2019-06-28 | $39.66M | 21.73% |
| 2019-03-29 | $32.58M | 4.48% |
| 2018-12-28 | $31.19M | -1.84% |
| 2018-09-28 | $31.77M | -6.30% |
| 2018-06-29 | $33.91M | 25.14% |
| 2018-03-30 | $27.09M | 9.02% |
| 2017-12-29 | $24.85M | 5.87% |
| 2017-09-29 | $23.47M | 7.01% |
| 2017-06-30 | $21.94M | 7.79% |
| 2017-03-31 | $20.35M | -8.07% |
| 2016-12-30 | $22.14M | 10.40% |
| 2016-09-30 | $20.05M | -4.40% |
| 2016-07-01 | $20.97M | 8.85% |
| 2016-04-01 | $19.27M | 2.77% |
| 2015-10-02 | $18.75M | 0.50% |
| 2015-07-03 | $18.66M | -1.07% |
| 2015-04-03 | $18.86M | 13.79% |
| 2015-01-02 | $16.57M | -8.88% |
| 2014-10-03 | $18.19M | -9.28% |
| 2014-07-04 | $20.05M | -0.64% |
| 2014-04-04 | $20.18M | 6.51% |
| 2014-01-03 | $18.94M | 10.74% |
| 2013-09-27 | $17.11M | -5.82% |
| 2013-06-28 | $18.16M | 0.91% |
| 2013-03-29 | $18.00M | 9.32% |
| 2012-12-28 | $16.47M | 3.79% |
| 2012-09-28 | $15.87M | -0.48% |
| 2012-06-29 | $15.94M | 2.79% |
| 2012-03-30 | $15.51M | -5.32% |
| 2011-12-30 | $16.38M | 7.30% |
| 2011-09-30 | $15.27M | -6.17% |
| 2011-07-01 | $16.27M | 9.56% |
| 2011-04-01 | $14.85M | 3.20% |
| 2010-12-31 | $14.39M | 9.41% |
| 2010-10-01 | $13.15M | -3.57% |
| 2010-07-02 | $13.64M | -1.01% |
| 2010-04-02 | $13.78M | -30.52% |
| 2010-01-01 | $19.83M | 9.48% |
| 2009-10-02 | $18.11M | -5.25% |
| 2009-07-03 | $19.12M | 4.56% |
| 2009-04-03 | $18.28M | 0.69% |
| 2009-01-02 | $18.16M | 0.25% |
| 2008-09-26 | $18.11M | -12.35% |
| 2008-06-27 | $20.66M | 15.06% |
| 2008-03-28 | $17.96M | 13.06% |
| 2007-12-28 | $15.88M | - |
STAAR Surgical Company generated $88.59M in revenue during Q3 2024, up -10.52% compared to the previous quarter, and up 95.97% compared to the same period a year ago.
STAAR Surgical Company Revenue Breakdown
STAAR Surgical Company Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 22 | Dec 21 | Jan 21 | Jan 20 | Dec 18 |
|---|---|---|---|---|---|
| Implantable Collamer Lenses | $269.71M | $212.91M | $141.41M | $129.32M | $101.08M |
| Cataract Intraocular Lenses | $9.64M | $12.52M | - | - | - |
| Other Surgical Products | $5.04M | $5.05M | $8.48M | $5.17M | $6.68M |
| Intraocular Lenses | - | - | $13.57M | $15.69M | $16.19M |
STAAR Surgical Company's latest annual revenue breakdown by segment (product or service), as of Dec 22: Implantable Collamer Lenses (94.84%), Cataract Intraocular Lenses (3.39%), and Other Surgical Products (1.77%).
Quarterly Revenue by Product
| Product/Service | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Apr 22 | Oct 21 | Jul 21 | Apr 21 | Jan 21 | Oct 20 | Jul 20 | Apr 20 | Jan 20 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Implantable Collamer Lenses | $89.10M | $77.15M | $319.43M | $81.07M | $93.11M | $70.63M | $61.16M | $71.95M | $77.92M | $58.67M | $54.15M | $59.23M | $46.50M | $39.85M | $41.49M | $30.73M | $29.34M | $33.29M | $33.81M | $34.43M |
| Other Surgical Products | - | $205.00K | $1.85M | $-540.00K | $-846.00K | $1.43M | $884.00K | $1.90M | $632.00K | $1.62M | $1.67M | $58.00K | $526.00K | $2.46M | $2.26M | $1.91M | $1.85M | $1.89M | $1.15M | $1.36M |
| Cataract Intraocular Lenses | - | - | $1.14M | $221.00K | $40.00K | $1.48M | $2.00M | $2.19M | $2.55M | $2.90M | $2.52M | - | - | - | - | - | - | - | - | - |
| Intraocular Lenses | - | - | - | - | - | - | - | - | - | - | - | $3.07M | $3.73M | $3.69M | $3.33M | $2.56M | $3.99M | $3.71M | $4.09M | $3.87M |
STAAR Surgical Company's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Implantable Collamer Lenses (100.00%).
STAAR Surgical Company Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 18 |
|---|---|
| Other Countries | $47.42M |
| CHINA | $46.07M |
| JAPAN | $23.15M |
| UNITED STATES | $7.32M |
STAAR Surgical Company's latest annual revenue breakdown by geography, as of Dec 18: Other Countries (38.25%), CHINA (37.17%), JAPAN (18.68%), and UNITED STATES (5.90%).
Quarterly Revenue by Country
| Country | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | Jun 18 | Mar 18 |
|---|---|---|---|---|---|---|---|
| JAPAN | $7.34M | $6.28M | $5.52M | $5.37M | $6.01M | $6.69M | $5.08M |
| Other Countries | $13.35M | $13.99M | $12.00M | $7.65M | $12.41M | $13.25M | $10.15M |
| CHINA | $18.36M | $19.39M | $11.77M | $10.85M | $13.35M | $13.96M | $7.91M |
| KOREA, REPUBLIC OF | - | - | $3.29M | $2.19M | - | - | - |
| UNITED STATES | - | - | - | - | - | - | $1.76M |
STAAR Surgical Company's latest quarterly revenue breakdown by geography, as of Sep 19: CHINA (47.01%), Other Countries (34.18%), and JAPAN (18.81%).
STAAR Surgical Company Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| BDX | Becton, Dickinson and Company | $19.37B | $4.99B |
| RMD | ResMed | $4.69B | $1.22B |
| HOLX | Hologic | $4.03B | $1.01B |
| COO | Cooper Companies | $3.59B | $1.00B |
| ATR | AptarGroup | $3.49B | $909.29M |
| WST | West Pharmaceutical Services | $2.95B | $746.90M |
| NVST | Envista | $2.57B | $884.70M |
| ICUI | ICU Medical | $2.26B | $596.46M |
| HAE | Haemonetics | $1.31B | $336.17M |
| MMSI | Merit Medical Systems | $1.26B | $339.85M |
| RGEN | Repligen | $638.76M | $154.07M |
| ANGO | AngioDynamics | $303.91M | $67.49M |
| STAA | STAAR Surgical Company | $322.42K | $88.59M |
| MBOT | Microbot Medical | - | - |
STAA Revenue FAQ
What is STAAR Surgical Company’s yearly revenue?
STAAR Surgical Company's yearly revenue for 2023 was $322.42K, representing a decrease of -99.89% compared to 2022. The company's yearly revenue for 2022 was $284.39M, representing an increase of 23.40% compared to 2021. STAA's yearly revenue for 2021 was $230.47M, representing an increase of 41.00% compared to 2020.
What is STAAR Surgical Company’s quarterly revenue?
STAAR Surgical Company's quarterly revenue for Q3 2024 was $88.59M, a -10.52% decrease from the previous quarter (Q2 2024), and a 10.31% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $99M, a 27.99% increase from the previous quarter (Q1 2024), and a 7.26% increase year-over-year (Q2 2023). STAA's quarterly revenue for Q1 2024 was $77.36M, a 1.42% increase from the previous quarter (Q4 2023), and a 5.21% increase year-over-year (Q1 2023).
What is STAAR Surgical Company’s revenue growth rate?
STAAR Surgical Company's revenue growth rate for the last 3 years (2021-2023) was -99.86%, and for the last 5 years (2019-2023) was -99.79%.
What are STAAR Surgical Company’s revenue streams?
STAAR Surgical Company's revenue streams in c 22 are Implantable Collamer Lenses, Cataract Intraocular Lenses, and Other Surgical Products. Implantable Collamer Lenses generated $269.71M in revenue, accounting 94.84% of the company's total revenue, up 26.68% year-over-year. Cataract Intraocular Lenses generated $9.64M in revenue, accounting 3.39% of the company's total revenue, down -23.01% year-over-year. Other Surgical Products generated $5.04M in revenue, accounting 1.77% of the company's total revenue, down -0.14% year-over-year.
What is STAAR Surgical Company’s main source of revenue?
For the fiscal year ending Dec 22, the largest source of revenue of STAAR Surgical Company was Implantable Collamer Lenses. This segment made a revenue of $269.71M, representing 94.84% of the company's total revenue.